Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Clinical trial NCT06136546 · RECRUITING

Trial details

NCT number: NCT06136546
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major Inflammation

Start date: 2025-01-23
Primary completion: 2028-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.